tirzepatide mounjaro uk is second obesity drug to be approved for use in England | Obesity Tirzepatide For Weight Loss: Uses,

Clinical trial data from the SURMOUNT programme demonstrated significant average body weight reductions in participants using tirzepatide compared to placebo

Participants in the clinical trial lost 50.3 pounds, compared with 33.1 pounds for participants on Wegovy, which was approved in the U.S

Your healthcare provider is the best person to help you decide if Zepbound is right for you

Our team is committed to providing personalized, compassionate care that empowers you to take control of your health.

Its a part of the city that blends urban convenience with suburban comfort, and our clinic serves that full range of patients with individualized weight loss and hormone care built around clinical evidence